These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31679761)

  • 21. Refractoriness to platelet transfusion following partial hepatectomy for hepatocellular carcinoma: report of two cases.
    Kaibori M; Nagahama T; Yokoigawa N; Yanagida H; Nakamoto H; Kitade H; Satoi S; Onishi S; Kwon AH; Kamiyama Y
    Hepatogastroenterology; 2003; 50(51):832-6. PubMed ID: 12828097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of platelet refractoriness in oncohematologic patients.
    Ferreira AA; Zulli R; Soares S; Castro Vd; Moraes-Souza H
    Clinics (Sao Paulo); 2011; 66(1):35-40. PubMed ID: 21437433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.
    Stanworth SJ; Navarrete C; Estcourt L; Marsh J
    Br J Haematol; 2015 Nov; 171(3):297-305. PubMed ID: 26194869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion.
    Ikeda H; Mitani T; Ohnuma M; Haga H; Ohtzuka S; Kato T; Nakase T; Sekiguchi S
    Vox Sang; 1989; 57(3):213-7. PubMed ID: 2617957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
    Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.
    Pappalardo PA; Secord AR; Quitevis P; Haimowitz MD; Goldfinger D
    Transfusion; 2001 Aug; 41(8):984-7. PubMed ID: 11493728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants.
    Jackman RP; Deng X; Bolgiano D; Lebedeva M; Heitman JW; Busch MP; Slichter SJ; Norris PJ
    Blood; 2013 Apr; 121(16):3261-6; quiz 3299. PubMed ID: 23393051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P
    Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelets Structure, Function and Modulator Capacity in Replacement Therapy.
    Moutinho B; Pinto B; Cardoso R; Botelho MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):180-184. PubMed ID: 29283062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet transfusion for patients with cancer.
    Fletcher CH; DomBourian MG; Millward PA
    Cancer Control; 2015 Jan; 22(1):47-51. PubMed ID: 25504278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions.
    Abraham AS; Chacko MP; Fouzia NA; Srivastava A; Daniel D
    Transfus Med; 2018 Oct; 28(5):392-397. PubMed ID: 29460307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets.
    Van Osch TLJ; Oosterhoff JJ; Bentlage AEH; Nouta J; Koeleman CAM; Geerdes DM; Mok JY; Heidt S; Mulder A; Van Esch WJE; Kapur R; Porcelijn L; Van der Schoot CE; De Haas M; Wuhrer M; Voorberg J; Vidarsson G
    Haematologica; 2022 Oct; 107(10):2432-2444. PubMed ID: 35354253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model.
    Gras C; Schulze K; Goudeva L; Guzman CA; Blasczyk R; Figueiredo C
    Hum Gene Ther; 2013 Dec; 24(12):1018-28. PubMed ID: 24090417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.